🇺🇸 Fluticasone/Formoterol in United States

208 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 34 reports (16.35%)
  2. Asthma — 33 reports (15.87%)
  3. Drug Intolerance — 24 reports (11.54%)
  4. Dyspnoea — 24 reports (11.54%)
  5. Bronchitis — 17 reports (8.17%)
  6. Obstructive Airways Disorder — 16 reports (7.69%)
  7. Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome — 15 reports (7.21%)
  8. Breath Sounds Abnormal — 15 reports (7.21%)
  9. Bronchial Hyperreactivity — 15 reports (7.21%)
  10. Cardiac Disorder — 15 reports (7.21%)

Source database →

Other Respiratory/Pulmonology approved in United States

Frequently asked questions

Is Fluticasone/Formoterol approved in United States?

Fluticasone/Formoterol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Fluticasone/Formoterol in United States?

Mundipharma Korea Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.